Doxil, Bevacizumab and Temsirolimus Trial

Clinical trial NCT00761644 · COMPLETED

Trial details

NCT number: NCT00761644
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2008-08-21
Primary completion: 2019-03-28
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.